Peacock A, Leung J, Larney S, Colledge S, Hickman M, Rehm J, et al. Global statistics on alcohol, tobacco and illicit drug use: 2017 status report. Addiction. 2018;113:1905–26.

Article  PubMed  Google Scholar 

Han B, Volkow ND, Compton WM, McCance-Katz EF. Reported heroin use, use disorder, and injection among adults in the United States, 2002-2018. JAMA. 2020;323:568–71.

Article  PubMed  PubMed Central  Google Scholar 

Volkow ND, McLellan TA. Curtailing diversion and abuse of opioid analgesics without jeopardizing pain treatment. JAMA. 2011;305:1346–7.

Article  CAS  PubMed  Google Scholar 

Herlinger K, Lingford-Hughes A. Opioid use disorder and the brain: a clinical perspective. Addiction (Abingdon, England). 2022;117:495–505.

Article  PubMed  Google Scholar 

United Nations Office on Drugs and Crime (UNODC). World Drug Report. 2021. Available from: https://www.unodc.org/unodc/en/data-and-analysis/wdr2021.html

Ahmad FB, Cisewski JA, Rossen LM, Sutton P. Provisional drug overdose death counts. National Center for Health Statistics. 2023. Available from: https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm

Volkow ND, Normand J. The international HIV/AIDS pandemic has been closely inter-twined with drug abuse and addiction from the time it began. Preface. Drug Alcohol Depend. 2013;132:S1.

de Cock KM, Jaffe HW, Curran JW. Reflections on 40 Years of AIDS. Emerg Infect Dis. 2021;27:1553.

Article  PubMed  PubMed Central  Google Scholar 

Sullivan PS, Satcher Johnson A, Pembleton ES, Stephenson R, Justice AC, Althoff KN, et al. Epidemiology of HIV in the USA: epidemic burden, inequities, contexts, and responses. Lancet. 2021;397:1095–106.

Article  PubMed  Google Scholar 

Ellis R, Langford D, Masliah E. HIV and antiretroviral therapy in the brain: neuronal injury and repair. Nat Rev Neurosci. 2007;8:33–44.

Article  CAS  PubMed  Google Scholar 

Degenhardt L, Peacock A, Colledge S, Leung J, Grebely J, Vickerman P, et al. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet. Glob Health. 2017;5:e1192–e1207.

Google Scholar 

Amin P, Douaihy A. Substance use disorders in people living with human immunodeficiency virus/AIDS. Nurs Clin N Am. 2018;53:57–65.

Article  Google Scholar 

Ventuneac A, Hecht G, Forcht E, Duah BA, Tarar S, Langenbach B, et al. Chronic high risk prescription opioid use among persons with HIV. Front Sociol. 2021;6:645992.

Article  PubMed  PubMed Central  Google Scholar 

Parker R, Stein DJ, Jelsma J. Pain in people living with HIV/AIDS: a systematic review. J Int AIDS Soc. 2014;17:18719.

Article  PubMed  PubMed Central  Google Scholar 

Miaskowski C, Penko JM, Guzman D, Mattson JE, Bangsberg DR, Kushel MB. Occurrence and characteristics of chronic pain in a community-based cohort of indigent adults living with HIV infection. J Pain. 2011;12:1004–16.

Article  PubMed  PubMed Central  Google Scholar 

Canan C, Alexander GC, Moore R, Murimi I, Chander G, Lau B. Medicaid trends in prescription opioid and non-opioid use by HIV status. Drug Alcohol Depend. 2019;197:141–8.

Article  PubMed  PubMed Central  Google Scholar 

Canan CE, Chander G, Monroe AK, Gebo KA, Moore RD, Agwu AL, et al. High-risk prescription opioid use among people living with HIV. J Acquir Immune Defic Syndr. 2018;78:283–90.

Article  PubMed  PubMed Central  Google Scholar 

Lemons A, DeGroote N, Peréz A, Craw J, Nyaku M, Broz D, et al. Opioid misuse among HIV-positive adults in medical care: results from the Medical Monitoring Project, 2009-2014. J Acquir Immune Defic Syndr. 2019;80:127–34.

Article  PubMed  PubMed Central  Google Scholar 

Merlin JS, Long D, Becker WC, Cachay ER, Christopoulos KA, Claborn K, et al. Brief report: the association of chronic pain and long-term opioid therapy with HIV treatment outcomes. J Acquir Immune Defic Syndr. 2018;79:77–82.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Edelman EJ, Gordon K, Becker WC, Goulet JL, Skanderson M, Gaither JR, et al. Receipt of opioid analgesics by HIV-infected and uninfected patients. J Gen Intern Med. 2013;28:82–90.

Article  PubMed  Google Scholar 

Hartzler B, Dombrowski JC, Crane HM, Eron JJ, Geng EH, Christopher Mathews W, et al. Prevalence and predictors of substance use disorders among HIV care enrollees in the United States. AIDS Behav. 2017;21:1138–48.

Article  PubMed  PubMed Central  Google Scholar 

Tsao JCI, Plankey MW, Young MA. Pain, psychological symptoms and prescription drug misuse in HIV: a literature review. J Pain Manag. 2012;5:111.

PubMed  PubMed Central  Google Scholar 

Robinson-Papp J, Elliott K, Simpson DM, Morgello S. Problematic prescription opioid use in an HIV-infected cohort: the importance of universal toxicology testing. J Acquir Immune Defic Syndr. 2012;61:187–93.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vijayaraghavan M, Freitas D, Bangsberg DR, Miaskowski C, Kushel MB. Non-medical use of non-opioid psychotherapeutic medications in a community-based cohort of HIV-infected indigent adults. Drug Alcohol Depend. 2014;143:263–7.

Article  PubMed  PubMed Central  Google Scholar 

Becker WC, Gordon K, Jennifer Edelman E, Kerns RD, Crystal S, Dziura JD, et al. Trends in any and high-dose opioid analgesic receipt among aging patients with and without HIV. AIDS Behav. 2016;20:679–86.

Article  PubMed  PubMed Central  Google Scholar 

Degenhardt L, Charlson F, Ferrari A, Santomauro D, Erskine H, Mantilla-Herrara A, et al. The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. Psychiatry. 2018;5:987–1012.

Google Scholar 

Moore DJ, Blackstone K, Woods SP, Ellis RJ, Atkinson JH, Heaton RK, et al. Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence. AIDS Care. 2012;24:1504–13.

Article  PubMed  PubMed Central  Google Scholar 

Blackard JT, Sherman KE. Drugs of abuse and their impact on viral pathogenesis. Viruses. 2021;13:2387.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Volkow ND, Koob GF, McLellan AT. Neurobiologic advances from the brain disease model of addiction. N Engl J Med. 2016;374:363–71.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Everall I, Vaida F, Khanlou N, Lazzaretto D, Achim C, Letendre S, et al. Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy. J Neurovirol. 2009;15:360–70.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Masliah E, Heaton RK, Marcotte TD, Ellis RJ, Wiley CA, Mallory M, et al. Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center. Ann Neurol. 1997;42:963–72.

Article  CAS  PubMed  Google Scholar 

Nash B, Festa L, Lin C, Meucci O. Opioid and chemokine regulation of cortical synaptodendritic damage in HIV-associated neurocognitive disorders. Brain Res. 2019;1723:146409.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fitting S, Knapp PE, Zou S, Marks WD, Scott Bowers M, Akbarali HI, et al. Interactive HIV-1 Tat and morphine-induced synaptodendritic injury is triggered through focal disruptions in Na+ influx, mitochondrial instability, and Ca2+ overload. J Neurosci. 2014;34:12850–64.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fitting S, Xu R, Bull C, Buch SK, El-Hage N, Nath A, et al. Interactive comorbidity between opioid drug abuse and HIV-1 Tat: chronic exposure augments spine loss and sublethal dendritic pathology in